MASHINIi

COSCIENS Biopharma Inc..

CSCI.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

COSCIENS Biopharma Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies. The company's pipeline includes drug candidates targeting various diseases. COSCIENS Biopharma leverages its research and development capabilities to advance i...Show More

Ethical Profile

Mixed.

COSCIENS Biopharma Inc. (CSCI.US) has faced challenges regarding financial transparency. The Ontario Securities Commission (OSC) issued a Management Cease Trade Order (MCTO) on April 1, 2025, due to a potential delay in filing annual financial statements, raising concerns about compliance. However, the company operates a whistleblower program via EthicsPoint, emphasizing confidentiality and protection against retaliation, alongside a Code of Conduct revised in 2024. While COSCIENS develops health-focused products like Macrilen/Ghryvelin and various nutraceuticals, reports suggest a potential tension between profitability and product accessibility. Many other ethical areas, including fair pay, ethical sourcing, and environmental impact, lack sufficient public data for a comprehensive assessment.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess COSCIENS Biopharma Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess COSCIENS Biopharma Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

The company has no specific regulatory actions, violations, fines, or compliance issues mentioned in the provided articles.

1

Fair Trade & Ethical Sourcing

0

No evidence available to assess COSCIENS Biopharma Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-40

COSCIENS Biopharma Inc. is subject to a Management Cease Trade Order (MCTO) issued by the Ontario Securities Commission (OSC) on April 1, 2025, due to a potential delay in filing annual financial statements for December 31, 2024, 2023, and 2022, and related CEO/CFO certificates and annual information form by the March 31, 2025 deadline.

1
This order restricts trading in the company's securities by the CEO and CFO until the required filings are made.
2
The company has a whistleblower program managed by EthicsPoint, offering multiple reporting channels (phone and online) in various languages, and emphasizes confidentiality and protection against retaliation for reporting concerns.
3
However, there is no evidence of independent investigation processes for whistleblower reports.

Kind to Animals

0

No specific, concrete data points were found in the provided articles regarding COSCIENS Biopharma Inc.'s performance on any of the 'Kind to Animals' KPIs. The articles discuss corporate updates, clinical trial results, and general FDA policy changes regarding animal testing, but do not provide information on the company's cruelty-free certifications, alternative testing usage, animal testing policies or volume, ethical sourcing, or any other animal welfare-related metrics specific to COSCIENS Biopharma Inc.

No War, No Weapons

0

No evidence available to assess COSCIENS Biopharma Inc. on No War, No Weapons.

Planet-Friendly Business

0

No relevant quantitative data or specific facts regarding COSCIENS Biopharma Inc.'s environmental performance, policies, or initiatives were found in the provided article.

1
The article explicitly states that it contains no quantitative data, regulatory actions, certifications, or industry benchmarks, and its content is entirely placeholder text.
2

Respect for Cultures & Communities

0

No evidence available to assess COSCIENS Biopharma Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

No evidence available to assess COSCIENS Biopharma Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No evidence available to assess COSCIENS Biopharma Inc. on Zero Waste & Sustainable Products.

Own COSCIENS Biopharma Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.